Avidity Biosciences Appoints Sarah Boyce as Chief Executive Officer
LA JOLLA, Calif., Oct. 1, 2019 -- (Healthcare Sales & Marketing Network)-- Avidity Biosciences, a privately-held biotechnology company pioneering Antibody Oligonucleotide Conjugates (AOCs™), announced today the appointment of global business leader Sarah...Biopharmaceuticals, Personnel
Avidity Biosciences, Antibody-Oligonucleotide Conjugates
Read more »